New Test Can Pinpoint Which Pancreatic Cysts Might Turn Cancerous
Title: New Test Can Pinpoint Which Pancreatic Cysts Might Turn CancerousCategory: Health NewsCreated: 7/17/2019 12:00:00 AMLast Editorial Review: 7/18/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - July 18, 2019 Category: Cancer & Oncology Source Type: news

Type 2 diabetes: A popular food item for lunch you must AVOID - increases symptoms
TYPE 2 diabetes is when the pancreas does not make enough insulin or when the body can no longer use the insulin it makes. A popular lunch item could make symptoms worse and increase a person ’s risk. What is it? (Source: Daily Express - Health)
Source: Daily Express - Health - July 18, 2019 Category: Consumer Health News Source Type: news

Many of the deadliest cancers receive the least amount of research funding
(Northwestern University) Many of the deadliest or most common cancers get the least amount of nonprofit research funding, reports a new Northwestern Medicine study. 'Embarrassing' or stigmatized cancers, like lung and liver, are underfunded. Colon, endometrial, liver and bile duct, cervical, ovarian, pancreatic and lung cancers were all poorly funded compared to how common they are and how many deaths they cause, the study found. In contrast, breast cancer, leukemia, lymphoma and pediatric cancers were all well-funded, respective to their impact on society. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 18, 2019 Category: Cancer & Oncology Source Type: news

New Test Can Pinpoint Which Pancreatic Cysts Might Turn Cancerous
WEDNESDAY, July 17, 2019 -- To have surgery or not to have surgery? That is the big question for hundreds of thousands of Americans diagnosed each year with a pancreatic cyst. The dilemma? While cysts are very common, most will not actually lead to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 17, 2019 Category: General Medicine Source Type: news

Machine learning platform guides pancreatic cyst management in patients
(American Association for the Advancement of Science) Researchers have created a comprehensive test based on machine learning algorithms to better guide the management of patients with pancreatic cysts -- a potential precursor of pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 17, 2019 Category: Cancer & Oncology Source Type: news

Test shown to improve accuracy in identifying precancerous pancreatic cysts
(Johns Hopkins Medicine) CompCyst, a new test developed by researchers at the Johns Hopkins Kimmel Cancer Center distinguishes pancreatic cysts that are destined to become cancer and need to be surgically removed from cysts that can be left alone without causing harm. The researchers believe CompCyst has the capacity to substantially reduce unnecessary surgeries for pancreatic cysts. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 17, 2019 Category: Cancer & Oncology Source Type: news

New insight into the biology of insulin release
n a new study, Yale researchers challenge a long-held assumption about how insulin-producing cells in the pancreas sense and respond to glucose. (Source: Yale Science and Health News)
Source: Yale Science and Health News - July 16, 2019 Category: Universities & Medical Training Source Type: news

Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer
Stabilization of the MYC oncoprotein by KRAS signaling critically promotes the growth of pancreatic ductal adenocarcinoma (PDAC). Thus, understanding how MYC protein stability is regulated may lead to effective therapies. Here, we used a previously developed, flow cytometry–based assay that screened a library of>800 protein kinase inhibitors and identified compounds that promoted either the stability or degradation of MYC in a KRAS-mutant PDAC cell line. We validated compounds that stabilized or destabilized MYC and then focused on one compound, UNC10112785, that induced the substantial loss of MYC protein in both...
Source: Signal Transduction Knowledge Environment - July 16, 2019 Category: Science Authors: Blake, D. R., Vaseva, A. V., Hodge, R. G., Kline, M. P., Gilbert, T. S. K., Tyagi, V., Huang, D., Whiten, G. C., Larson, J. E., Wang, X., Pearce, K. H., Herring, L. E., Graves, L. M., Frye, S. V., Emanuele, M. J., Cox, A. D., Der, C. J. Tags: STKE Research Articles Source Type: news

CT perfusion shows promising utility in cancer treatment
The CT perfusion scans of patients with pancreatic cancer revealed that those...Read more on AuntMinnie.comRelated Reading: CT matches MRI for late-window stroke evaluation Is CT or MR perfusion better for diagnosing CAD? Perfusion imaging expands window for stroke treatment CTA plus stress tests help predict heart attacks ISCT: Is CT perfusion dead beyond the head? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 11, 2019 Category: Radiology Source Type: news

Cancer patients in the UK will test drug to reduce weight loss and fatigue caused by the disease
The drug bermekimab has been hailed as 'radical' by experts. Patients with lung, pancreatic and ovarian cancer will be the first to be recruited by researchers at the University of Edinburgh. (Source: the Mail online | Health)
Source: the Mail online | Health - July 10, 2019 Category: Consumer Health News Source Type: news

Robotic pancreas transplant offers hope for obese patients with Type 1 diabetes
(University of Illinois at Chicago) Surgeons at UI Health have demonstrated that obese patients with Type 1 diabetes can safely receive a pancreas transplant when the surgery is performed robotically. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 10, 2019 Category: International Medicine & Public Health Source Type: news

Intermittent fasting protects mice from type 2 diabetes
(Society for the Study of Ingestive Behavior) Every-other-day fasting substantially reduces the likelihood of developing type 2 diabetes in mice eating a fat-rich diet, according to new research out of the German Institute of Human Nutrition Potsdam-Rehbruecke. These findings, presented this week at the annual meeting of the Society for the Study of Ingestive Behavior in Utrecht, Netherlands, suggest that periodic fasting can reduce fat accumulation in the pancreas and, in turn, prevent the onset of type 2 diabetes. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 9, 2019 Category: International Medicine & Public Health Source Type: news

What Are Common Presentations for Budd-Chairi in Adolescents?
Discussion Budd-Chiari syndrome (BCS) is a rare liver disease caused by hepatic venous outflow obstruction (HVOTO). The obstruction can be anywhere from the small intrahepatic veins up to the inferior vena cava junction with the right atrium. The liver parenchyma itself is not directly affected but becomes compromised because of the increased hepatic sinusoidal pressure over time. The causes include: prothrombic events (35% of cases such as Protein C or Protein S deficiency, Factor V Leiden or antithrombin deficiency), myeloproliferative conditions, oral contraceptive use, and local factors. BCS can occur in any age but i...
Source: PediatricEducation.org - July 8, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Discovery of mechanism behind precision cancer drug opens door for more targeted treatment
(University of Alberta Faculty of Medicine& Dentistry) New research that uncovers the mechanism behind the newest generation of cancer drugs is opening the door for better targeted therapy. PARP inhibitors are molecular targeted cancer drugs used to treat women with ovarian cancer who have the BRCA1 and BRCA2 gene mutations. The drugs are showing promise in late-stage clinical trials for breast cancer, prostate cancer and pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 4, 2019 Category: Cancer & Oncology Source Type: news

Society congratulates our new Early Career Grant awardees
Congratulations to our early career members awardedEarly Career Grants of up to£10,000 to help fund their endocrine research.Patricio Atanes(King’s College London) - Identifying obesity-induced targets in the human liver GPCR expressome: therapeutic implications fortype 2 diabetes and non-alcoholic fatty liver diseaseIoannis Christakis (University of Nottingham) - Evaluating a potential adrenal-gut axis as a therapy for Sub-Clinical Cushing’s SyndromeShelley Harris (OCDEM) - Dissecting the role of role of 5β-reductase in pancreatic islet cell morphology and hormone secretionInmaculada...
Source: Society for Endocrinology - July 3, 2019 Category: Endocrinology Source Type: news

Discovery of pancreatic neuroendocrine subtypes could help predict likelihood of recurrence
(Dana-Farber Cancer Institute) Researchers have discovered two distinct subtypes of pancreatic neuroendocrine tumors - known as pNETs - that have dramatically different risks of recurrence following surgical treatment [or surgery]. The finding could yield predictive tests, ease anxiety in patients whose tumors are found to be unlikely to recur, while focusing vigilant follow-up monitoring on patients with pNETs having a higher rate of recurrence. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 3, 2019 Category: Cancer & Oncology Source Type: news

Reprogramming pancreatic cancer
(Rush University Medical Center) A type of white blood cell that has been especially susceptible to being deceived by pancreatic cancer cells into not attacking them can be 're-programmed' via a specially designed molecule that activates a protein found on their surfaces. The finding, which are the cover story of the July 3, 2019 issue of the Science Translational Medicine. Despite being the 3rd leading cause of cancer deaths, only 3% of immunotherapies address pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 3, 2019 Category: Cancer & Oncology Source Type: news

Immune-boosting compound makes immunotherapy effective against pancreatic cancer
(Washington University School of Medicine) Researchers at Washington University School of Medicine in St. Louis and Rush University in Chicago have found a compound that promotes a vigorous immune assault on pancreatic cancer. The findings, in mice, suggest a way to improve immunotherapy for the deadly disease in patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 3, 2019 Category: Cancer & Oncology Source Type: news

Promising approach: Prevent diabetes with intermittent fasting
(Deutsches Zentrum fuer Diabetesforschung DZD) Intermittent fasting is known to improve sensitivity to the blood glucose-lowering hormone insulin and to protect against fatty liver. DZD scientists from DIfE have now discovered that mice on an intermittent fasting regimen also exhibited lower pancreatic fat. In their current study published in the journal Metabolism, the researchers showed the mechanism by which pancreatic fat could contribute to the development of type 2 diabetes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 2, 2019 Category: International Medicine & Public Health Source Type: news

Metformin May Cut Mortality Risk in Post-Pancreatitis Diabetes
MONDAY, July 1, 2019 -- Metformin use may promote a survival benefit in individuals with post-pancreatitis diabetes mellitus (PPDM), but not pancreatic cancer-related diabetes (PCRD), according to a study published online June 21 in Diabetes... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 1, 2019 Category: Pharmaceuticals Source Type: news

NETRF-funded research may help predict pancreatic neuroendocrine tumor (pNET) recurrence
(Neuroendocrine Tumor Research Foundation) NETRF-funded researchers identified a cancer cell type that is associated with non-functional pancreatic neuroendocrine tumor (pNET) recurrence. Alpha-like pNET cell expression of the protein ARX can guide prognosis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 1, 2019 Category: Cancer & Oncology Source Type: news

Cancer cell's 'self eating' tactic may be its weakness
(Cold Spring Harbor Laboratory) Researchers reveal how pancreatic cancer cells adapt to the low energy environment of a tumor: by eating their own mitochondria! Now, by targeting this process, researchers hope to halt cancer cell proliferation. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 1, 2019 Category: Cancer & Oncology Source Type: news

Tumor Microenvironment and Pancreatic Cancer Therapy Tumor Microenvironment and Pancreatic Cancer Therapy
Chemoresistance and radioresistance are common in pancreatic ductal adenocarcinoma. Do pharmacologic agents address these challenges?Chinese Clinical Oncology (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - June 28, 2019 Category: Allergy & Immunology Tags: Hematology-Oncology Journal Article Source Type: news

New insights into beta cell dysfunction
An international collaboration has developed methodology, published inNature Metabolism, that will enable them to more effectively investigate why pancreatic beta cells stop producing insulin in diabetes. Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - June 27, 2019 Category: Endocrinology Source Type: news

Nutritional cues regulate pancreatic tumor's 'cell drinking'
(Sanford Burnham Prebys Medical Discovery Institute) Desperate for nutrients, rapidly growing pancreatic tumors resort to scavenging 'fuel' through an alternative supply route, called macropinocytosis. Blocking this process, often described as 'cellular drinking,' could lead to tumor-starving drugs. Now, scientists from Sanford Burnham Prebys have identified a signaling pathway that regulates macropinocytosis, the nutritional cue that triggers the process and key metabolic differences between tumors -- revealing new directions for drug development and patient treatment. The findings were published in Developmental Cell. (S...
Source: EurekAlert! - Cancer - June 27, 2019 Category: Cancer & Oncology Source Type: news

Celebrating 40 Years: 2010s Medtech Milestones
Click here to check out the previous decade, 2000s Medtech Milestones Or, for further reading on the above-mentioned milestones, check out the following links: A Near-Term Look At Medtech Investing Abbott to Stop Selling Absorb Bos Sci Exec on the Secret to Synergy's Success An Exoskeleton First: FDA Clears ReWalk 2015 Medtech Company of the Year Finalists: ReShape Medical Grail Sets Fast Pace in Liquid Biopsy with New Milestones Medtronic Artificial Pancreas Wins FDA Approval​​​​​​​ The Bleeding Ed...
Source: MDDI - June 26, 2019 Category: Medical Devices Authors: MDDI Staff Tags: Business Source Type: news

Widespread disease diabetes: Why do beta cells refuse to release insulin?
(Technische Universit ä t Dresden) One in 11 adults worldwide suffers from diabetes, and the number of diabetes patients is rising rapidly. Diabetes is worldwide one of the most widespread diseases. In the most common form of diabetes, type 2 diabetes, the body cells react increasingly insensitively to the hormone insulin, which is produced by beta cells in the pancreas and is intended to promote the absorption of sugar from the blood into the cells. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 26, 2019 Category: Biology Source Type: news

What the Science Really Says About Grilled Meat and Cancer Risk
As backyard cookout season kicks into high gear, many people may be eyeing their sizzling burgers and dogs with suspicion. And for good reason: a number of studies published in the past two decades have turned up evidence that eating charred, smoked, and well-done meat could raise cancer risk—pancreatic, colorectal, and prostate cancers, in particular. A 2010 review of the evidence on cancer and “well-done” meat, conducted by researchers at Vanderbilt University, concluded that “the majority of these studies have shown that high intake of well-done meat and high exposure to meat carcinogens, particu...
Source: TIME: Health - June 25, 2019 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Cancer Diet & Fitness Nutrition Source Type: news

6 Market Forces Changing the Medical Device World
As a high school junior, I was shown the guts of an implantable defibrillator. That day, I quit my pursuit of a career in medicine to pursue one in medical device design. OK, so my life didn’t go quite that linearly, but many years later I continue to work on life-improving technologies from the consulting side of medical device design. This pursuit continues to be a great passion. The medical device market is in the popular press spotlight these days. Actually, it’s more of a target. Netflix’s documentary The Bleeding Edge explored whether the 510(k) FDA clearance proc...
Source: MDDI - June 24, 2019 Category: Medical Devices Authors: Jesse Darley Tags: Business Source Type: news

Cochrane's 30 under 30: Meisam Abdar Esfahani
Cochrane is made up of  11,000 members and over 67,000 supporters come from more than 130 countries, worldwide. Our volunteers and contributors are researchers, health professionals, patients, carers, people passionate about improving health outcomes for everyone, everywhere.Cochrane is an incredible community of people who all play their part in improving health and healthcare globally. We believe that by putting trusted evidence at the heart of health decisions we can achieve a world of improved health for all.  Many  of our contributors are young people working with Cochrane ...
Source: Cochrane News and Events - June 24, 2019 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Children with diabetes have smaller pancreases
According to a study, published inDiabetic Medicine, the pancreas in children with type 1 diabetes is smaller, which may affect its function.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - June 24, 2019 Category: Endocrinology Source Type: news

AI can improve reproducibility of radiomics in CT
An artificial intelligence (AI) algorithm may be able to help overcome one...Read more on AuntMinnie.comRelated Reading: 6 ways AI will enhance musculoskeletal imaging Can radiomics detect pancreatic ductal adenocarcinoma? AI, radiomics can help predict chemotherapy response AI may predict lymph node metastasis in gastric cancer AI singles out high-risk prostate cancer on mpMRI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 24, 2019 Category: Radiology Source Type: news

Long thought harmless, a glycan biomarker may cause pancreatic disease and cancer
(American Association for the Advancement of Science) A widely recognized biomarker for pancreatic disease, CA19-9, thought to be benign for decades, may in fact be a promoter for the development of these diseases, including pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 20, 2019 Category: Cancer & Oncology Source Type: news

Sugars that coat proteins are a possible drug target for pancreatitis
(Cold Spring Harbor Laboratory) CA19-9 is a complex sugar structure that coats proteins. Elevated levels of CA19-9 was found to cause inflammation in the pancreas in mice and promote rapid progression to pancreatic cancer. By neutralizing the functions of CA19-9 with antibodies, researchers were able to reduce and even prevent pancreatic damage in animal models. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 20, 2019 Category: Cancer & Oncology Source Type: news

The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice
Glycosylation alterations are indicative of tissue inflammation and neoplasia, but whether these alterations contribute to disease pathogenesis is largely unknown. To study the role of glycan changes in pancreatic disease, we inducibly expressed human fucosyltransferase 3 and β1,3-galactosyltransferase 5 in mice, reconstituting the glycan sialyl-Lewisa, also known as carbohydrate antigen 19-9 (CA19-9). Notably, CA19-9 expression in mice resulted in rapid and severe pancreatitis with hyperactivation of epidermal growth factor receptor (EGFR) signaling. Mechanistically, CA19-9 modification of the matricellular protein f...
Source: ScienceNOW - June 20, 2019 Category: Science Authors: Engle, D. D., Tiriac, H., Rivera, K. D., Pommier, A., Whalen, S., Oni, T. E., Alagesan, B., Lee, E. J., Yao, M. A., Lucito, M. S., Spielman, B., Da Silva, B., Schoepfer, C., Wright, K., Creighton, B., Afinowicz, L., Yu, K. H., Grützmann, R., Aust, Tags: Medicine, Diseases r-articles Source Type: news

Type 2 diabetes: The best diet to eat to improve blood sugar levels and protect the brain
TYPE 2 diabetes is caused by poor insulin production in the pancreas causing blood sugar levels to soar. Very high blood sugar levels over a long period of time can damage vital parts of the body such as eyes, nerves, kidneys and blood vessels. It may come as a surprise that it can also affect the brain - but there is a diet that can help protect the brain. (Source: Daily Express - Health)
Source: Daily Express - Health - June 18, 2019 Category: Consumer Health News Source Type: news

The truth about the healing powers of tumericĀ 
Curcumin may even improve the function of the insulin-producing cells in the pancreas, important for controlling blood sugar levels, as one early study, published in Diabetes Care in 2012, found. (Source: the Mail online | Health)
Source: the Mail online | Health - June 18, 2019 Category: Consumer Health News Source Type: news

The Most Effective Diet For Reducing The Worst Kind Of Fat
The study, known as the CENTRAL trial, demonstrated that a low-carb Mediterranean diet had a more significant effect on reducing fat around the liver (hepatic fat), heart and the pancreas, compared to low-fat diets with similar calorie counts, although the weight loss was similar. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 17, 2019 Category: Pharmaceuticals Authors: Robert Glatter, MD, Contributor Source Type: news

Type 2 diabetes: Eating this vegetable could lower blood sugar
TYPE 2 diabetes is a common condition that is caused by a poor insulin production in the pancreas leading to uncontrolled blood sugar levels. One popular ingredient could help lower blood sugar levels. Are you getting enough in your diet? (Source: Daily Express - Health)
Source: Daily Express - Health - June 16, 2019 Category: Consumer Health News Source Type: news

WVU researcher studies new treatment for pancreatic cancer
(West Virginia University) If the American Cancer Society's projections prove accurate, more people will die from pancreatic cancer than from breast, brain, ovarian or prostate cancer this year. WVU researcher Brian Boone was part of a team that studied a new combination of drugs to treat pancreatic cancer. In their meta-analysis, the drug combination -- FOLFIRINOX -- was associated with better surgical options and longer overall survival. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2019 Category: International Medicine & Public Health Source Type: news

Chinese medicine formula Wu-Mei-wan found to prevent Type 2 diabetes
(Natural News) In these two studies, researchers from Huazhong University of Science and Technology in China investigated the mechanisms underlying wu mei wan’s ability to protect pancreatic beta cells and reduce insulin resistance. The results of their studies were published in BMC Complementary and Alternative Medicine and Evidence-Based Complementary and Alternative Medicine, respectively. Wu mei wan (WMW) is... (Source: NaturalNews.com)
Source: NaturalNews.com - June 13, 2019 Category: Consumer Health News Source Type: news

Pancreatic cancer: Are you aware of the six main risks?
PANCREATIC cancer has the lowest survival rate of all common cancers in the UK, with five-year survival less than seven percent. It is not exactly clear what causes pancreatic cancer but there are six main risk factors. (Source: Daily Express - Health)
Source: Daily Express - Health - June 13, 2019 Category: Consumer Health News Source Type: news

Special fibroblasts help pancreatic cancer cells evade immune detection
(Cold Spring Harbor Laboratory) A subpopulation of fibroblasts called apCAFs can interact with the immune system to help pancreatic cancer cells avoid detection. Understanding how they work can be key in developing therapeutics for pancreatic ductal adenocarcinoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 13, 2019 Category: Cancer & Oncology Source Type: news

Type 2 diabetes: Do you sleep like this? The sleeping pattern that increases diabetes risk
TYPE 2 diabetes is a serious condition that involves the insulin made by the pancreas not working properly. Sleeping patterns could increase the risk of developing type 2 diabetes. Are you at risk? (Source: Daily Express - Health)
Source: Daily Express - Health - June 12, 2019 Category: Consumer Health News Source Type: news

Immunotherapy and diabetes: A game of hide and seek?
(Osaka University) Immune checkpoint inhibitors (ICIs) are emerging as an effective treatment for certain cancers, but in rare cases can cause autoimmune diseases. Researchers at Osaka University explored a unique case of a patient with cancer whose pancreas was removed, and who was diagnosed with type 1 diabetes (an autoimmune disease) after receiving ICIs. The researchers stained tissue samples from the pancreas, allowing them to better understand the link between checkpoint inhibitors and type 1 diabetes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 11, 2019 Category: Cancer & Oncology Source Type: news

Novel Neoadjuvant Approach May Boost Surgical Success in Pancreatic Cancer Novel Neoadjuvant Approach May Boost Surgical Success in Pancreatic Cancer
In the majority of studied patients with locally advanced pancreatic cancer, total neoadjuvant treatment with fluorouracil, leucovorin, oxaliplatin and irinotecan (FOLFIRINOX) along with losartan and chemoradiation allowed complete tumor removal, according to a single-arm phase 2 trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 10, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Using tumor biomarkers to tailor therapy in metastatic pancreatic cancer
(Mary Ann Liebert, Inc./Genetic Engineering News) A new pilot study demonstrated the feasibility of using molecular tumor markers as the basis for selecting the chemotherapeutic agents to use in patients with metastatic pancreatic cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 10, 2019 Category: International Medicine & Public Health Source Type: news

How not being able to flush my stools led to a cancer diagnosis
EXCLUSIVE: Chris Davey, 59, of Bristol, visited his GP about his change in stools and itchy skin. He was one of the very few to be diagnosed with pancreatic cancer early and receive surgery. (Source: the Mail online | Health)
Source: the Mail online | Health - June 7, 2019 Category: Consumer Health News Source Type: news

Advances in pancreatic cancer treatment extending lives: Mayo Clinic Radio Health Minute
Pancreatic cancer is one of the deadliest forms of cancer, and such a diagnosis has long been considered a death sentence. In this Mayo Clinic Radio Health Minute we hear from Dr. Mark Truty, a Mayo Clinic cancer surgeon, who along with a team of surgeons and oncologists published a study which found that with [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 7, 2019 Category: Databases & Libraries Source Type: news